Ruijin Hospital
Clinical trials sponsored by Ruijin Hospital, explained in plain language.
-
Heart bypass patients get new drug comparison to keep grafts open longer
Disease control OngoingThis study looks at 150 people who had coronary artery bypass surgery using a radial artery graft. It compares three oral medications—nicorandil, diltiazem, and isosorbide mononitrate—to see which best prevents graft spasms and keeps the graft working well. Participants take one …
Phase: PHASE4 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
Can a simple oil stop bedsores before they start?
Prevention ENROLLING_BY_INVITATIONThis study tests whether a natural oil made from palmitoleic acid can prevent pressure injuries (bedsores) in hospital patients at high risk. Researchers will apply the oil to the skin and use special scanners to detect early signs of damage. The goal is to stop bedsores from for…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Prevention
Last updated May 06, 2026 16:03 UTC
-
Zapping depression: new brain device offers hope for tough cases
Symptom relief OngoingThis study tests a new type of brain stimulation (HD-ctACS) for people with depression that hasn't improved with standard treatments. Ten adults will receive both the real stimulation and a sham (fake) version at different times to see if it safely reduces depressive symptoms. Th…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated May 06, 2026 16:13 UTC
-
AI and PET scans join forces to predict lung complications in rare muscle disease
Knowledge-focused OngoingThis study aims to create a new way to diagnose interstitial lung disease (ILD) in people with dermatomyositis, a rare muscle condition. Researchers will use special PET/CT scans and machine learning to build a model that predicts ILD. The study involves 200 participants and does…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:14 UTC
-
Blood gene clue could unlock sepsis mysteries
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at a gene called TRIM25 in blood cells of people with sepsis, a life-threatening infection response. Researchers will compare gene activity and inflammatory markers between 65 sepsis patients and non-sepsis controls. The goal is to find biological clues that coul…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:13 UTC